ArticleJournal of thrombosis and thrombolysis2015
Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.
Faiza Yasmeen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it